Filed: 5/15/2024ACC: 0000919574-24-003094
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $17.55M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$17.55M
Total AUM (reported)
6.70M
Total Shares
Allocation by class
COM$11.98M68.3%
COM NEW$3.94M22.5%
TR UNIT$971.0K5.5%
CL B NEW$428.3K2.4%
SPONSORED ADS$226.1K1.3%
Portfolio Concentration
Top 3$15.63M89.1%
4–10$1.88M10.7%
11–25$41.1K0.2%
Top 3 weight
89.1%
Top 10 weight
99.8%
Voting Authority Distribution
Total shares with voting rights: 6.70M
Sole
Full voting authority
6.70M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
XERIS BIOPHARMA HOLDINGS INC
SOLEShares5.11M
TypeSH
Market value$11.30M
64.38%
Sole
5.11M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.32M
TypeSH
Market value$3.36M
19.16%
Sole
1.32M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares1.86K
TypeSH
Market value$971.0K
5.53%
Sole
1.86K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares1.02K
TypeSH
Market value$428.3K
2.44%
Sole
1.02K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares15.85K
TypeSH
Market value$393.6K
2.24%
Sole
15.85K
Shared
0.00
None
0.00
MOLECULAR TEMPLATES INC
SOLEShares136.87K
TypeSH
Market value$306.6K
1.75%
Sole
136.87K
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares29.07K
TypeSH
Market value$273.2K
1.56%
Sole
29.07K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares15.81K
TypeSH
Market value$226.1K
1.29%
Sole
15.81K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares10.32K
TypeSH
Market value$161.8K
0.92%
Sole
10.32K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares43.47K
TypeSH
Market value$86.1K
0.49%
Sole
43.47K
Shared
0.00
None
0.00
ADICET BIO INC
SOLEShares17.49K
TypeSH
Market value$41.1K
0.23%
Sole
17.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 5.11M | SH | $11.30M 64.38% | 5.11M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.32M | SH | $3.36M 19.16% | 1.32M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 1.86K | SH | $971.0K 5.53% | 1.86K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 1.02K | SH | $428.3K 2.44% | 1.02K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 15.85K | SH | $393.6K 2.24% | 15.85K | 0.00 | 0.00 |
MOLECULAR TEMPLATES INCSOLE | COM NEW | 136.87K | SH | $306.6K 1.75% | 136.87K | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 29.07K | SH | $273.2K 1.56% | 29.07K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 15.81K | SH | $226.1K 1.29% | 15.81K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 10.32K | SH | $161.8K 0.92% | 10.32K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 43.47K | SH | $86.1K 0.49% | 43.47K | 0.00 | 0.00 |
ADICET BIO INCSOLE | COM | 17.49K | SH | $41.1K 0.23% | 17.49K | 0.00 | 0.00 |